Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 1-year average of -8595.61%, near the high end of its 1-year range (-34382.43%–0.00%).
100.00% above its 12-month average of -11460.81%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -34382.43%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
-11460.81%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 836 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Parabilis Medicines, Inc.
Market Cap
$3.33B
Operating Margin
0.00%
TTM Avg
-11460.81%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.40B
Operating Margin
7.59%
TTM Avg
16.94%
3Y Avg
-4.86%
5Y Avg
-19.92%
Market Cap
$3.39B
Operating Margin
-21982.57%
TTM Avg
-10991.28%
3Y Avg
-7569.11%
5Y Avg
-5786.72%
Market Cap
$3.47B
Operating Margin
-72.84%
TTM Avg
-2371.95%
3Y Avg
-1360.37%
5Y Avg
-967.05%
Market Cap
$3.19B
Operating Margin
-8.00%
TTM Avg
-40.81%
3Y Avg
-286.27%
5Y Avg
-194.40%
Market Cap
$3.48B
Operating Margin
-4974.27%
TTM Avg
-2487.14%
3Y Avg
-1585.80%
5Y Avg
-1144.82%
Market Cap
$3.48B
Operating Margin
-178.39%
TTM Avg
-262.24%
3Y Avg
-320.96%
5Y Avg
-353.79%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.33B | 0.00% | -11460.81% | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.38B | -0.92% | 2.81% | -22.73% | -18.78% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.40B | 7.59% | 16.94% | -4.86% | -19.92% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.39B | -21982.57% | -10991.28% | -7569.11% | -5786.72% |
| Celcuity Inc. (CELC)vs › | $3.48B | 0.00% | 0.00% | 0.00% | 0.00% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.47B | -72.84% | -2371.95% | -1360.37% | -967.05% |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | -8.00% | -40.81% | -286.27% | -194.40% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.48B | -4974.27% | -2487.14% | -1585.80% | -1144.82% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.48B | -178.39% | -262.24% | -320.96% | -353.79% |
| Veracyte, Inc. (VCYT)vs › | $3.53B | 17.03% | 8.98% | -4.91% | -14.51% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -34382.43% |
| 2026-03-31 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
